MELANOMA CONSORTIUM 2026
May 15, 2026
In 1988, Dr. Hilliard Seigler organized the first Duke Melanoma Consortium. For nearly 30years patients, families, and friends have come to Durham on a yearly basis to learn aboutadvances in melanoma. Dr. Seigler was a practicing melanoma surgeon at Duke Universityfor over 40 years, he led groundbreaking research efforts in melanoma and dedicated hiscareer to the care of patients and families with melanoma. Given his lifetime of commitment,we are pleased to announce that the event will now be formally known as the HilliardSeigler Duke Melanoma Consortium, the Seig DMC.
This course is open for anyone to attend;please find registration info at this website: dukeseiglermelanomaconsortium.org
Target Audience
- Allied Health Professionals
- Fellows
- Medical Students
- Nurses
- Nurse Practitioners
- Physicians
- Physician Assistants
- Pharmacy Technicians
- Pharmacists
- Residents
Learning Objectives
- Identify advances in medical oncology, surgical oncology, and radiation oncology practices for melanoma.
- Optimize efforts in recognition, timely diagnosis and management strategies through case presentation and multidisciplinary discussion of complex melanoma cases by treating specialties involved in care.
- Recognize risk factors, signs and symptoms, and melanoma care available at Duke and across the globe.
- April Salama MD
- Paul Mosca MD
- Manisha Palta MD
- Brandon Howard MD
- M Angelica Selim MD
- Smita Nair MD
- Riddish Shah MD
- Cameron Oswalt MD
- Jay Lee MD
- Esther Yu MD
- Eric Powers MD
- Kimberly Breglio, MD
- Georgia Beasley MD
- Sunandana Chandra, MD
- ACPE - Pharmacy Technician
- ACPE - Pharmacist
- AMA PRA Category 1 Credit(s)
- ANCC
- IACET CEU
- JA Credit - AH
- Attendance
Available Credit
- 2.00 ACPE - Pharmacist
- 2.00 ACPE - Pharmacy Technician
- 2.00 AMA PRA Category 1 Credit(s)™
- 2.00 ANCC
- 2.00 Attendance
- 0.20 IACET CEU
- 2.00 JA Credit - AH
- 2.00 Approved for AMA PRA Category 1 Credit(s)™

Facebook
X
LinkedIn
Forward